ELISA measurement for urinary 3-hydroxyproline-containing peptides and its preliminary application to healthy persons and cancer patients

Anticancer Res. 2010 Mar;30(3):1007-14.

Abstract

Background/aim: We reported that endogenous urinary 3-hydroxyproline (3-Hyp) is useful for cancer screening because cancer invasion involves the destruction of basement membrane. A simple and sensitive assay is desired.

Patients and methods: An ELISA method using a specific antibody against a synthetic peptide of 10 amino acids including 3-Hyp corresponding to the amino acid sequences of collagen type IV alpha chain was applied to urine samples from 180 healthy controls and 22 cancer patients.

Results: The values in controls were 2.44+/-1.90 (SD) mg peptide/g creatinine for 52 men and 2.87+/-2.01 for 128 women, while the values in 22 cancer patients were very low at 0.110+/-0.137 (p<0.001).

Discussion: The discrepancy in the data between our previous and present studies is based on the difference of targets measured. 3-Hyp-containing peptides in cancer patients might be destroyed by the elevated peptidase levels found in these patients.

Conclusion: This ELISA assay may be useful for cancer screening.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies / chemistry
  • Biomarkers, Tumor / urine*
  • Case-Control Studies
  • Colonic Neoplasms / urine
  • Enzyme-Linked Immunosorbent Assay / methods*
  • Female
  • Humans
  • Hydroxyproline / urine*
  • Male
  • Mass Screening
  • Middle Aged
  • Neoplasms / urine*
  • Pancreatic Neoplasms / urine
  • Peptides / urine*
  • Stomach Neoplasms / urine

Substances

  • Antibodies
  • Biomarkers, Tumor
  • Peptides
  • Hydroxyproline